TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LQDA

Liquidia Technologies Inc

Healthcare · Drug Manufacturers - Specialty & Generic

66.90$ -2.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LQDA
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
37.1% 36.9% 81.0% 81.9% 66.4% 65.4% 77.3% 76.0% 80.4% 58.1%
17.0% 23.0% 80.0% 81.0% 65.6% 61.3% 72.2% 70.7% 76.6% 58.1%
17.0% 23.0% 80.0% 81.0% 65.6% 61.3% 72.2% 70.7% 76.6% 58.1%
14.6% 10.9% 0.6% 0.0% 3.2% 3.9% 3.4% 1.2% 16.5%
0.0% 0.0% 0.0% 0.0% 0.1% 7.3%
51.2% 55.5% 16.5% 17.5% 9.5% 7.9% 4.8%
3.9% 4.2% 3.0% 3.3% 1.7% 1.2%
5.6% 4.7% 2.9% 2.9% 1.4% 0.9%
315.0% 327.0% 62.2% 49.2% 28.6% 30.4% 30.0% 60.0% 66.4% 86.4%
142.5% 205.6% 16.7% 24.5% 11.8% 7.8% 6.8% 15.7% 18.1% 41.4%
38.0% 108.3% 1.6% 10.7% 1.6% 1.2% 0.8% 3.2% 8.0% 18.0%
28.4% 29.8% 6.5% 5.1% 3.8% 1.1% 1.7% 1.2% 2.0% 1.1%
61.5% 37.4% 23.5% 15.0% 10.3% 11.1% 15.4% 36.7% 42.3% 40.5%
-215.0% -227.0% 37.8% 50.8% 71.4% 69.6% 70.0% 40.0% 33.6% 13.6%
-992.9% -764.1% -338.0% -312.7% -276.3% -330.3% -271.4% -362.6% -242.9% -191.0%
60.0% 57.8% 14.5% 26.8% 34.0% 53.0% 47.2% 54.9% 34.2% 26.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?